This Article Full Text Full Text (PDF) All Versions of this Article: 200207-678OCv1 167/6/828    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Olivier, K. N. Articles by Knowles, M. R. Search for Related Content PubMed PubMed Citation Articles by Olivier, K. N. Articles by Knowles, M. R.

Nontuberculous Mycobacteria

I: Multicenter Prevalence Study in Cystic Fibrosis

The Cystic Fibrosis/Pulmonary Research and Treatment Center, the Departments of Epidemiology and Biostatistics, and the Verne S. Caviness General Clinical Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Pulmonary/Critical Care Medicine Flight, Wilford Hall United States Air Force Medical Center, Lackland Air Force Base, Texas; the Division of Allergy/Immunology and Respiratory Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina; and the Department of Microbiology, University of Texas Health Center at Tyler, Tyler, Texas

Correspondence and requests for reprints should be addressed to Kenneth N. Olivier, M.D., M.P.H., Wilford Hall USAF Medical Center, 759 MSGS/MCCP (Pulmonary/Critical Care), 2200 Bergquist Drive, Ste 1, Lackland AFB, TX 78236-5300. E-mail: kenneth.olivier{at}lackland.af.mil

Nontuberculous mycobacteria (NTM) are potential respiratory pathogens in cystic fibrosis (CF). To assess the species-specific prevalence and risk factors for acquisition, we conducted a prospective, cross-sectional study of the prevalence of NTM and clinical features of patients at 21 U.S. centers. Almost 10% of patients with CF who were 10 years or older were included (n = 986). The overall prevalence of NTM in sputum was 13.0% (range by center, 7–24%). Mycobacterium avium complex (72%) and Mycobacterium abscessus (16%) were the most common species. When compared with patients with CF without NTM, culture-positive subjects were older (26 vs. 22 years, p < 0.001), had a higher FEV₁ (60 vs. 54%, p < 0.01), higher frequency of Staphylococcus aureus (43 vs. 31%, p < 0.01), and lower frequency of Pseudomonas aeruginosa (71 vs. 82%, p < 0.01). Molecular typing revealed that almost all patients within each center had unique NTM strains. In summary, NTM are common in patients with CF, but neither person-to-person nor nosocomial acquisition explained the high prevalence. Older age was the most significant predictor for isolation of NTM. The clinical significance of NTM in CF is incompletely defined, but patients with these organisms should be monitored with repeat cultures.

Key Words: cystic fibrosis • nontuberculous mycobacteria • mycobacterium infections • Mycobacterium avium-intracellulare • Mycobacterium abscessus

This article has been cited by other articles:

				J S. Elborn Identification and management of unusual pathogens in cystic fibrosis J R Soc Med, July 1, 2008; 101(Supplement_1): 2 - 5. [Full Text] [PDF]

				P. Sexton and A. C. Harrison Susceptibility to nontuberculous mycobacterial lung disease Eur. Respir. J., June 1, 2008; 31(6): 1322 - 1333. [Abstract] [Full Text] [PDF]

				R. Greendyke and T. F. Byrd Differential Antibiotic Susceptibility of Mycobacterium abscessus Variants in Biofilms and Macrophages Compared to That of Planktonic Bacteria Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2019 - 2026. [Abstract] [Full Text] [PDF]

				A. S. Teirstein Help for the Diagnosis of Some, but Not All Cases of Mycobacterium avium-Complex Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 677 - 679. [Full Text] [PDF]

				A Smyth and J S Elborn Exacerbations in cystic fibrosis: 3 {middle dot} Management Thorax, February 1, 2008; 63(2): 180 - 184. [Abstract] [Full Text] [PDF]

				M. P. Boyle Adult Cystic Fibrosis JAMA, October 17, 2007; 298(15): 1787 - 1793. [Abstract] [Full Text] [PDF]

				W. R. Butler, C. A. Sheils, B. A. Brown-Elliott, N. Charles, A. A. Colin, M. J. Gant, J. Goodill, D. Hindman, S. R. Toney, R. J. Wallace Jr., et al. First Isolations of Segniliparus rugosus from Patients with Cystic Fibrosis J. Clin. Microbiol., October 1, 2007; 45(10): 3449 - 3452. [Abstract] [Full Text] [PDF]

				B. E. Jonsson, M. Gilljam, A. Lindblad, M. Ridell, A. E. Wold, and C. Welinder-Olsson Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis J. Clin. Microbiol., May 1, 2007; 45(5): 1497 - 1504. [Abstract] [Full Text] [PDF]

				D. E. Griffith, T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 367 - 416. [Full Text] [PDF]

				M. Dailloux, M. L. Abalain, C. Laurain, L. Lebrun, C. Loos-Ayav, A. Lozniewski, J. Maugein, and the French Mycobacteria Study Group Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients Eur. Respir. J., December 1, 2006; 28(6): 1211 - 1215. [Abstract] [Full Text] [PDF]

				S. J. Fowler, J. French, N. J. Screaton, J. Foweraker, A. Condliffe, C. S. Haworth, A. R. Exley, and D. Bilton Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics Eur. Respir. J., December 1, 2006; 28(6): 1204 - 1210. [Abstract] [Full Text] [PDF]

				T. M. Ziedalski, P. N. Kao, N. R. Henig, S. S. Jacobs, and S. J. Ruoss Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest, October 1, 2006; 130(4): 995 - 1002. [Abstract] [Full Text] [PDF]

				A. Ferroni, H. Vu-Thien, P. Lanotte, M. Le Bourgeois, I. Sermet-Gaudelus, B. Fauroux, S. Marchand, F. Varaigne, P. Berche, J.-L. Gaillard, et al. Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. J. Clin. Microbiol., June 1, 2006; 44(6): 2237 - 2239. [Abstract] [Full Text] [PDF]

				S. T. Howard, E. Rhoades, J. Recht, X. Pang, A. Alsup, R. Kolter, C. R. Lyons, and T. F. Byrd Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype Microbiology, June 1, 2006; 152(6): 1581 - 1590. [Abstract] [Full Text] [PDF]

				S. K. Field and R. L. Cowie Lung Disease Due to the More Common Nontuberculous Mycobacteria Chest, June 1, 2006; 129(6): 1653 - 1672. [Abstract] [Full Text] [PDF]

				W Chalermskulrat, N Sood, I P Neuringer, T M Hecker, L Chang, M P Rivera, L J Paradowski, and R M Aris Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation Thorax, June 1, 2006; 61(6): 507 - 513. [Abstract] [Full Text] [PDF]

				K. L. Horan, R. Freeman, K. Weigel, M. Semret, S. Pfaller, T. C. Covert, D. van Soolingen, S. C. Leao, M. A. Behr, and G. A. Cangelosi Isolation of the Genome Sequence Strain Mycobacterium avium 104 from Multiple Patients over a 17-Year Period. J. Clin. Microbiol., March 1, 2006; 44(3): 783 - 789. [Abstract] [Full Text] [PDF]

				J. S. Kim, N. Tanaka, J. D. Newell, M. A. DeGroote, K. Fulton, G. Huitt, and D. A. Lynch Nontuberculous Mycobacterial Infection: CT Scan Findings, Genotype, and Treatment Responsiveness Chest, December 1, 2005; 128(6): 3863 - 3869. [Abstract] [Full Text] [PDF]

				C. Pierre-Audigier, A. Ferroni, I. Sermet-Gaudelus, M. Le Bourgeois, C. Offredo, H. Vu-Thien, B. Fauroux, P. Mariani, A. Munck, E. Bingen, et al. Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis J. Clin. Microbiol., July 1, 2005; 43(7): 3467 - 3470. [Abstract] [Full Text] [PDF]

				B. Konig, I. Tammer, V. Sollich, and W. Konig Intra- and Interpatient Variability of the hsp65 and 16S-23S Intergenic Gene Region in Mycobacterium abscessus Strains from Patients with Cystic Fibrosis J. Clin. Microbiol., July 1, 2005; 43(7): 3500 - 3503. [Abstract] [Full Text] [PDF]

				S C Bell, S L Senini, and J G McCormack Macrolides in cystic fibrosis Chronic Respiratory Disease, April 1, 2005; 2(2): 85 - 98. [Abstract] [PDF]

				D. M. Rodman, J. M. Polis, S. L. Heltshe, M. K. Sontag, C. Chacon, R. V. Rodman, S. J. Brayshaw, G. A. Huitt, M. D. Iseman, M. T. Saavedra, et al. Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 621 - 626. [Abstract] [Full Text] [PDF]

				H. Mussaffi, J. Rivlin, I. Shalit, M. Ephros, and H. Blau Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy Eur. Respir. J., February 1, 2005; 25(2): 324 - 328. [Abstract] [Full Text] [PDF]

				S. K. Field, D. Fisher, and R. L. Cowie Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection Chest, August 1, 2004; 126(2): 566 - 581. [Abstract] [Full Text] [PDF]

				P. G. Noone, M. W. Leigh, A. Sannuti, S. L. Minnix, J. L. Carson, M. Hazucha, M. A. Zariwala, and M. R. Knowles Primary Ciliary Dyskinesia: Diagnostic and Phenotypic Features Am. J. Respir. Crit. Care Med., February 15, 2004; 169(4): 459 - 467. [Abstract] [Full Text] [PDF]

				M. J. Tobin Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 277 - 287. [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300. [Full Text] [PDF]

				L. Saiman and J. Siegel Infection Control in Cystic Fibrosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 57 - 71. [Abstract] [Full Text] [PDF]

				P. San Gabriel, J. Zhou, S. Tabibi, Y. Chen, M. Trauzzi, and L. Saiman Antimicrobial Susceptibility and Synergy Studies of Stenotrophomonas maltophilia Isolates from Patients with Cystic Fibrosis Antimicrob. Agents Chemother., January 1, 2004; 48(1): 168 - 171. [Abstract] [Full Text] [PDF]

				R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF]

				L. Saiman, B. C. Marshall, N. Mayer-Hamblett, J. L. Burns, A. L. Quittner, D. A. Cibene, S. Coquillette, A. Y. Fieberg, F. J. Accurso, and P. W. Campbell III Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa: A Randomized Controlled Trial JAMA, October 1, 2003; 290(13): 1749 - 1756. [Abstract] [Full Text] [PDF]

				D. E. Griffith Emergence of Nontuberculous Mycobacteria as Pathogens in Cystic Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 810 - 812. [Full Text] [PDF]

				K. N. Olivier, D. J. Weber, J.-H. Lee, A. Handler, G. Tudor, P. L. Molina, J. Tomashefski, and M. R. Knowles Nontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 835 - 840. [Abstract] [Full Text] [PDF]